Rebates to pharmacy benefit managers are a hidden contributor to high drug prices
(By Douglas Hoey for STAT) In the furor over high drug prices, both Congress and the media have largely focused
Read More
Part D/Prescription Drugs
A Frenzy Of Lobbying On 21st Century Cures
(By Sydney Lupkin for Kaiser Health News) The 21st Century Cures Act set for a House vote Wednesday is one of the
Read MoreCostco probed in Canada over alleged kickback scheme for generics
(By Ed Silverman for STAT) A behind-the-scenes clash in Canada over generic competition has ensnared two Costco pharmacy directors, who
Read MoreDecember 7th Deadline is fast approaching
The deadline for Medicare open enrollment is December 7th; have you made your choice? If not, here are five simple
Read MoreEli Lilly’s Alzheimer’s drug fails in late-stage trial, dashing hopes
(By Damian Garde for STAT) An investigational Alzheimer’s treatment from Eli Lilly failed to slow the progression of the memory-destroying
Read MoreTwo patient deaths halt trial of Juno’s new approach to treating cancer
(By Damian Garde and Meghana Keshavan for STAT) In a major blow to a new approach to treating cancer, two patients
Read MoreHoping to attack opioid epidemic at its source, state Medicaid programs are limiting prescriptions
(By Shefali Luthra for Kaiser Health News published in partnership with STAT) As the abuse of prescription painkillers stubbornly persists
Read MoreDrug side effects have led to increased ER visits in older Americans
(By Ed Silverman for STAT) Side effects from medication are causing more older Americans to visit emergency rooms and leading
Read MoreMylan refuses to testify at Senate hearing about EpiPen rebates to Medicaid
(By Ed Silverman for STAT) In a move that angered a key Senate lawmaker, Mylan Pharmaceuticals has declined to testify
Read MoreOmniPod: Why is it Still Not Covered under Medicare?
In an opinion editorial for the Morning Consult, George Grunberger, M.D., chairman of the Grunberger Diabetes Institute, urges the Centers
Read More